ID
14817
Description
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00915369
Link
https://clinicaltrials.gov/show/NCT00915369
Keywords
Versions (1)
- 4/29/16 4/29/16 -
Uploaded on
April 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Breast Cancer NCT00915369
Eligibility Advanced Breast Cancer NCT00915369
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
er/pr positive status
Data type
boolean
Alias
- UMLS CUI [1]
- C1719706
- UMLS CUI [2]
- C0069515
Description
her2+ detected with fish/cis
Data type
boolean
Alias
- UMLS CUI [1]
- C2316574
Description
hypersensitivity to paclitaxel or any other taxane
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0215136
Description
chemotherapy, hormonal therapy immunotherapy, therapy with biologicals or radiotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0021083
Description
cns lesions
Data type
boolean
Alias
- UMLS CUI [1]
- C0742468
Similar models
Eligibility Advanced Breast Cancer NCT00915369
- StudyEvent: Eligibility
C0205269 (UMLS CUI [1,2])
C0069515 (UMLS CUI [2])
C0215136 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2])